Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.

@article{Zhang2007RegulationOG,
  title={Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.},
  author={Hong-Mei Zhang and Shao‐Rui Chen and Hui-Lin Pan},
  journal={Journal of neurophysiology},
  year={2007},
  volume={97 1},
  pages={
          102-9
        }
}
Activation of spinal muscarinic acetylcholine receptors (mAChRs) produces analgesia and inhibits dorsal horn neurons through potentiation of GABAergic/glycinergic tone and inhibition of glutamatergic input. To investigate the mAChR subtypes involved in the inhibitory effect of mAChR agonists on glutamate release, evoked excitatory postsynaptic currents (eEPSCs) were recorded in lamina II neurons using whole cell recordings in rat spinal cord slices. The nonselective mAChR agonist oxotremorine-M… 

Figures from this paper

Dynamic Control of Glutamatergic Synaptic Input in the Spinal Cord by Muscarinic Receptor Subtypes Defined Using Knockout Mice*
TLDR
It is demonstrated that activation of the M2 and M4 receptor subtypes inhibits synaptic glutamate release to dorsal horn neurons and M5 is the predominant receptor subtype that potentiates glutamatergic synaptic transmission in the spinal cord.
Sustained Inhibition of Neurotransmitter Release from Nontransient Receptor Potential Vanilloid Type 1-Expressing Primary Afferents by μ-Opioid Receptor Activation-Enkephalin in the Spinal Cord
TLDR
Data suggest that stimulation of μ-opioid receptors on non-TRPV1 afferent terminals causes extended inhibition of neurotransmitter release to spinal dorsal horn neurons, which provides a cellular basis to explain why the analgesic action of opioids on mechanonociception is prolonged when TRPV 1-expressing primary afferents are removed.
Differential Regulation of Primary Afferent Input to Spinal Cord by Muscarinic Receptor Subtypes Delineated Using Knockout Mice*
TLDR
Findings indicate that activation of presynaptic M2 and M4 subtypes reduces glutamate release from primary afferents, which differentially regulates nociceptive input to the spinal cord.
Muscarinic receptor subtypes differentially control synaptic input and excitability of cerebellum‐projecting medial vestibular nucleus neurons
TLDR
The findings suggest that M3 is the predominant post‐synaptic mAChR involved in muscarinic excitation of cerebellum‐projecting MVN neurons, which has important therapeutic implications for treating vestibular disorders with mA ChR subtype‐selective agents.
Muscarinic inhibition of recurrent glutamatergic excitation in frog tectum column prevents NMDA receptor activation on efferent neuron
TLDR
The muscarinic inhibition of glutamatergic recurrent transmission had critical influence on the activity of the tectum column, preventing the generation of an output signal through suppression of the NMDA receptor activation and establishing necessary conditions for returning of the network to its resting state.
Targets, receptors and effects of muscarinic neuromodulation on giant neurones of the rat dorsal cochlear nucleus
TLDR
The results indicate that pre‐ and postsynaptic muscarinic receptors mediate cholinergic modulation on giant cells, which may become particularly important in evoking contralateral excitatory responses under certain pathological conditions.
Neuroanatomical basis for cholinergic modulation of locomotor networks by sacral relay neurons with ascending lumbar projections
TLDR
It is suggested that variations in the sacral level of acetylcholine modulate the SCA‐induced locomotor rhythm via muscarinic receptor‐dependent mechanisms and that the modified activity of sacral VF neurons in the presence of anacetylcholinesterase inhibitor can be partially ascribed to the cholinergic components associated with them.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
M2, M3, and M4 Receptor Subtypes Contribute to Muscarinic Potentiation of GABAergic Inputs to Spinal Dorsal Horn Neurons
TLDR
It is suggested that M2 and M4 receptor subtypes play a predominant role in muscarinic potentiation of synaptic GABA release in the spinal cord and the M3 subtype also contributes to increased GABAergic tone in spinal dorsal horn by mus carinic agonists.
M 2 , M 3 , and M 4 Receptor Subtypes Contribute to Muscarinic Potentiation of GABAergic Inputs to Spinal Dorsal Horn Neurons
TLDR
To determine the role of receptor subtypes in the muscarinic agonist-induced synaptic GABA release in the spinal cord, spontaneous inhibitory postsynaptic currents (sIPSCs) were recorded in lamina II neurons using whole-cell voltage-clamp recordings in rat spinal cord slices and suggest M2 and M4 receptor sub types play a predominant role.
Role of Presynaptic Muscarinic and GABAB Receptors in Spinal Glutamate Release and Cholinergic Analgesia in Rats
TLDR
Data from this integrated study provide new information that acetylcholine inhibits the glutamatergic synaptic input to lamina II neurons through presynaptic muscarinic receptors.
Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors.
TLDR
The data suggest that clonidine inhibits the excitatory synaptic input to lamina II(o) neurons through activation of alpha(2)-adrenergic receptors located on the glutamatergic afferent terminals.
Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats
TLDR
Data suggest that the M3 subtype is present on the somatodendritic site of glycinergic neurones and is mainly responsible for muscarinic potentiation of Glycinergic input to spinal dorsal horn neurones.
Inhibition of Glutamatergic Synaptic Input to Spinal Lamina IIo Neurons by Presynaptic 2-Adrenergic Receptors
TLDR
The data suggest that clonidine inhibits the excitatory synaptic input to lamina IIo neurons through activation of 2-adrenergic receptors located on the glutamatergic afferent terminals, which likely plays an important role in the analgesic action produced by activation of the descending noradrenaline system and 2- adrenergic agonists.
Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro
TLDR
The results suggest that the most significant effect of dopamine and muscarine in the STN is to reduce inhibitory synaptic input by acting at presynaptic dopamine D2 and mus carinic M3 receptors, respectively.
...
1
2
3
4
5
...